Find uplifting stories about heroes, innovations, and solutions
8 results for "triple-negative breast cancer"
Women with triple-negative breast cancer, one of the deadliest forms, now have a treatment that nearly doubles how long they live without their disease worsening. A global trial shows the targeted therapy works far better than standard chemotherapy.
A breakthrough treatment is giving hope to women with triple-negative breast cancer, the most aggressive form of the disease. Results show patients lived nearly twice as long compared to standard treatment.
Tamara Scott went from marathon training to battling triple-negative breast cancer, and now she's crossing finish lines again. This May, she'll run Philadelphia's Broad Street Run as a powerful symbol of recovery.
Scientists have discovered a molecule that stops triple-negative breast cancer, the most aggressive form that often strikes younger women. The breakthrough treatment shows promise without the toxic side effects that plagued previous cancer therapies.
Scientists at Oregon Health & Science University created a molecule that shuts down a key enzyme cancer cells need to grow, causing tumors to shrink in mice with triple-negative breast cancer. The breakthrough could lead to new treatments for one of the deadliest forms of breast cancer.
Scientists discovered a powerful natural molecule from a Chinese plant that attacks the most aggressive form of breast cancer in a completely new way. The compound could open doors for patients who have run out of treatment options.
Texas A&M researchers discovered that natural compounds in dark sweet cherries significantly slowed tumor growth and reduced cancer spread in the most aggressive form of breast cancer. The breakthrough offers new hope for treating triple-negative breast cancer, which has limited treatment options.
Scientists have discovered an antibody that successfully halted triple-negative breast cancer in laboratory models, offering hope for one of the most difficult cancers to treat. This breakthrough could lead to better treatment options for thousands of women facing this aggressive disease.